Minovar announced that Minovar Tiankang, a wholly-owned subsidiary, recently received the “Drug Registration Certificate” for two dosage forms of sitagliptin metformin tablets approved and issued by the State Drug Administration.
美诺华：全资子公司获得西格列汀二甲双胍片药品注册证书
Menovar: Wholly-owned subsidiary obtains drug registration certificate for sitagliptin metformin tablets
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.